Results 271 to 280 of about 81,368 (303)

Photodynamic therapy in cholangiocarcinomas

Best Practice & Research Clinical Gastroenterology, 2004
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time of diagnosis are candidates for curative surgery. In patients with advanced non-resectable cholangiocarcinoma palliative treatment options are limited. Until now, insertion of endoprostheses for the treatment of cholestasis has been the method of choice.
openaire   +3 more sources

Photodynamic therapy for cancer

Nature Reviews Cancer, 2003
The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed. At present, PDT is being tested in the clinic for use in oncology--to treat cancers of the head and neck, brain, lung, pancreas, intraperitoneal cavity, breast, prostate and skin.
Dennis E J G J, Dolmans, Dai, Fukumura, Rakesh K, Jain   +2 more
openaire   +2 more sources

Photodynamic therapy and cancer

BMJ, 2009
Promising results need to be followed by development of more selective drugs Photodynamic therapy uses visible light, molecular oxygen (normally present in most tissues at adequate concentration), and an otherwise innocuous drug to destroy tumours.1 All three components are needed for the cytotoxic effect.
Brown, Stanley B., Ibbotson, Sally H.
openaire   +3 more sources

Intraperitoneal Photodynamic Therapy

2007
Peritoneal carcinomatosis and sarcomatosis are generally incurable problems for which there are few good treatment options. Intraperitoneal PDT is potentially an ideal therapy for peritoneal carcinomatosis because of its relatively superficial treatment effect.
K A, Cengel, E, Glatstein, S M, Hahn
openaire   +2 more sources

Lasers in Photodynamic Therapy

Nursing Clinics of North America, 1990
Photodynamic therapy has been shown to provide a reasonable alternative to other treatment modalities for patients with certain cancers, and in some cases may be the preferred treatment. Currently, photodynamic therapy is under FDA-approved clinical investigational trials in the treatment of tumors of the skin, bronchus, esophagus, bladder, head and ...
openaire   +2 more sources

Photodynamic Therapy for Cholangiocarcinoma

Seminars in Liver Disease, 2004
The prognosis of perihilar cholangiocarcinoma (CC) is limited by tumor spread along the biliary tree leading to refractory obstructive cholestasis, cholangitis, and liver failure. Palliation with biliary endoprostheses yields median survival times between 4 and 6 months for nonresectable CC.
openaire   +2 more sources

Photodynamic therapy for cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Surgery, 2001
The prognosis of nonresectable cholangiocarcinoma is dismal, and in Bismuth type III and IV tumors relief of jaundice is seldom achieved, despite successful endoprosthesis insertion. Therefore, we evaluated additional photodynamic therapy in patients who failed to respond to endoprostheses insertion.
openaire   +3 more sources

Photodynamic therapy

Current Problems in Cancer, 2002
openaire   +2 more sources

Photodynamic therapy

Australasian Journal of Dermatology, 2005
openaire   +2 more sources

Conquering the Hypoxia Limitation for Photodynamic Therapy

Advanced Materials, 2021
Yilin Wan, Lian-Hua Fu, Jing Lin
exaly